Alex has developed diverse content and methodological expertise in his fifteen years partnering with life science companies. This has involved leading a wide array of engagements with biotech, pharmaceutical, and diagnostics companies. Alex has unique expertise in oncology and patient-based forecasting that he has deployed working in both the U.S. and Europe supporting new product planning, portfolio strategy, launch readiness, commercialization strategy, and diligence support.
Prior to joining ClearView, Alex completed a B.S. & M.S. in Biology from the University of California at San Diego and an MBA from the Kellogg School of Management at Northwestern University. After transitioning away from the lab, he spent more than a decade assessing and improving R&D productivity for large pharma companies with the KMR Group and innovating in the commercial space as part of the Strategy & Portfolio Analysis team at IQVIA.
Debbi Amanti Belanger